Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications

Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat Rev Cancer, 17, 20, 10.1038/nrc.2016.108 Yohan, 2014, Applications of nanoparticles in nanomedicine, J Biomed Nanotechnol, 10, 2371, 10.1166/jbn.2014.2015 Baetke, 2015, Applications of nanoparticles for diagnosis and therapy of cancer, BJR, 88, 10.1259/bjr.20150207 Han, 2019, Applications of nanoparticles in biomedical imaging, Nanoscale, 11, 799, 10.1039/C8NR07769J Cherukuri, 2010, Targeted hyperthermia using metal nanoparticles, Adv Drug Deliv Rev, 62, 339, 10.1016/j.addr.2009.11.006 Xu, 2011, Targeted albumin-based nanoparticles for delivery of amphipathic drugs, Bioconjugate Chem, 22, 870, 10.1021/bc1002295 Zhao, 2010, Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles, Int J Nanomed, 5, 669 Martínez-Negro, 2017, Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells, Biochim Biophys Acta Gen Subj, 1861, 1737, 10.1016/j.bbagen.2017.03.010 Sánchez-Arribas, 2020, Biocompatible nanovector of siRNA consisting of Arginine-based cationic lipid forgene knockdown in cancer cells, ACS Appl Mater Interfaces, 12, 34536, 10.1021/acsami.0c06273 Sánchez-Arribas, 2020, Protein expression knockdown in cancer cells induced by a Gemini cationic lipid nanovector with histidine-based polar heads, Pharmaceutics, 12, 10.3390/pharmaceutics12090791 Parveen, 2012, Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging, Nanomedicine, 8, 147, 10.1016/j.nano.2011.05.016 Xia, 2017, Seed-mediated growth of colloidal metal nanocrystals, Angew Chem Int Ed, 56, 60, 10.1002/anie.201604731 Ling, 2015, Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications, Acc Chem Res, 48, 1276, 10.1021/acs.accounts.5b00038 Guo, 2015, A comprehensive review on synthesis methods for transition-metal oxide nanostructures, CrystEngComm, 17, 3551, 10.1039/C5CE00034C Guerrero‐Martínez, 2010, Recent progress on silica coating of nanoparticles and related nanomaterials, Adv Mater, 22, 1182, 10.1002/adma.200901263 Chen, 2019, Wet-chemicalsynthesis and applications of semiconductor nanomaterial-based epitaxial heterostructures, Nano-Micro Lett, 11, 86, 10.1007/s40820-019-0317-6 Nikam, 2018, Wet chemical synthesis of metal oxide nanoparticles: a review, CrystEngComm, 20, 5091, 10.1039/C8CE00487K Lundqvist, 2017, The nanoparticle protein corona formed in human blood or human blood fractions, PLoS One, 12, 10.1371/journal.pone.0175871 Cai, 2019, The crown and the scepter: roles of the protein corona in nanomedicine, Adv Mater, 31, 1805740, 10.1002/adma.201805740 Rivera-Gil, 2013, The challenge torelate the physicochemical properties of colloidal nanoparticles to their cytotoxicity, Acc Chem Res, 46, 743, 10.1021/ar300039j Mahmoudi, 2011, protein−nanoparticle interactions: opportunities and challenges, Chem Rev, 111, 5610, 10.1021/cr100440g Prozeller, 2019, Prevention of dominant IgG adsorption on nanocarriers in IgG-enriched blood plasma by clusterin precoating, Adv Sci, 6, 1802199, 10.1002/advs.201802199 Vroman, 1962, Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids, Nature, 196, 476, 10.1038/196476a0 Vroman, 1980, Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces, Blood, 55, 156, 10.1182/blood.V55.1.156.156 Vroman, 1958, Use of barium stearate to remove labile factor from plasma, J Mt Sinai Hosp N Y, 25, 261 Lynch, 2007, The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century, Adv Colloid Interface Sci, 134, 167, 10.1016/j.cis.2007.04.021 Cedervall, 2007, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, PNAS, 104, 2050, 10.1073/pnas.0608582104 Roach, 2005, Interpretation of protein adsorption: surface-induced conformational changes, J Am Chem Soc, 127, 8168, 10.1021/ja042898o Corbo, 2016, The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery, Nanomedicine, 11, 81, 10.2217/nnm.15.188 Falahati, 1863, A health concern regarding the protein corona, aggregation and disaggregation, Biochim Biophys Acta Gen Subj, 2019, 971 Giulimondi, 2019, Interplay of protein corona and immune cells controls blood residency of liposomes, Nat Commun, 10, 3686, 10.1038/s41467-019-11642-7 Ryvolova, 2012, Modern micro and nanoparticle-based imaging techniques, Sensors (Basel), 12, 14792, 10.3390/s121114792 Huang, 2011, Multimodality and nanoparticles in medical imaging, Dalton Trans, 40, 6087, 10.1039/c0dt01656j Bao, 2018, Magnetic iron oxide nanoparticles as T 1 contrast agents for magnetic resonance imaging, J Mater Chem C, 6, 1280, 10.1039/C7TC05854C Chapman, 2013, Nanoparticles for cancer imaging: the good, the bad, and the promise, Nano Today, 8, 454, 10.1016/j.nantod.2013.06.001 Chen, 2019, Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window, Nat Nanotechnol, 14, 465, 10.1038/s41565-019-0392-3 Kwon, 2019, FeSe quantum dots for in vivo multiphoton biomedical imaging, Sci Adv, 5, 10.1126/sciadv.aay0044 Boase, 2012, Molecular imaging with polymers, Polym Chem, 3, 1384, 10.1039/c2py20132a Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol Pharmaceutics, 5, 505, 10.1021/mp800051m Longmire, 2008, Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats, Nanomedicine (Lond), 3, 703, 10.2217/17435889.3.5.703 Manzano, 2020, Mesoporous silica nanoparticles for drug delivery, Adv Funct Mater, 30, 10.1002/adfm.201902634 Feng, 2010, Conjugated polymer nanoparticles for drug delivery and imaging, ACS Appl Mater Interfaces, 2, 2429, 10.1021/am100435k Kröger, 2018, Biocompatible single-chain polymer nanoparticles for drug delivery—a dual approach, ACS Appl Mater Interfaces, 10, 30946, 10.1021/acsami.8b07450 Han, 2007, Drug and gene delivery using gold nanoparticles, Nanobiotechnology, 3, 40, 10.1007/s12030-007-0005-3 Arruebo, 2007, Magnetic nanoparticles for drug delivery, Nano Today, 2, 22, 10.1016/S1748-0132(07)70084-1 Mendes, 2017, Gold nanoparticle approach to the selective delivery of gene silencing incancer—the case for combined delivery?, Genes (Basel), 8, 10.3390/genes8030094 Huo, 2019, Gold-DNA nanosunflowers for efficient gene silencing with controllable transformation, Sci Adv, 5, 10.1126/sciadv.aaw6264 Kievit, 2009, PEI-PEG-chitosan copolymer coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection, Adv Funct Mater, 19, 2244, 10.1002/adfm.200801844 Attia, 2019, An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites, J Pharm Pharmacol, 71, 1185, 10.1111/jphp.13098 Clemons, 2018, Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy, Langmuir, 34, 15343, 10.1021/acs.langmuir.8b02946 Rosenblum, 2018, Progress and challenges towards targeted delivery of cancer therapeutics, Nat Commun, 9, 1410, 10.1038/s41467-018-03705-y Yoo, 2019, Active targeting strategies using biological ligands for nanoparticle drug delivery systems, Cancers (Basel), 11, 10.3390/cancers11050640 Koo, 2011, In vivo targeted delivery of nanoparticles for theranosis, Acc Chem Res, 44, 1018, 10.1021/ar2000138 Ahijado-Guzmán, 2016, Intracellular pH-induced tip-to-tip assembly of gold nanorods for enhanced plasmonic photothermal therapy, ACS Omega, 1, 388, 10.1021/acsomega.6b00184 Espinosa, 2016, Cancer cell internalization of gold nanostars impacts their photothermal efficiency in vitro and in vivo: toward a plasmonic thermal fingerprint in tumoral environment, Adv Healthcare Mater, 5, 1040, 10.1002/adhm.201501035 Espinosa, 2016, Duality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment, ACS Nano, 10, 2436, 10.1021/acsnano.5b07249 Israel, 2020, Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain, J Control Release, 320, 45, 10.1016/j.jconrel.2020.01.009 Sánchez-Cabezas, 2019, Combining magnetic hyperthermia and dual T1/T2 MR imaging using highly versatile iron oxide nanoparticles, Dalton Trans, 48, 3883, 10.1039/C8DT04685A Guan, 2019, Simultaneous imaging and selective photothermal therapy through aptamer-driven Au nanosphere clustering, J Phys Chem Lett, 10, 183, 10.1021/acs.jpclett.8b03284 Poon, 2019, Elimination pathways of nanoparticles, ACS Nano, 13, 5785, 10.1021/acsnano.9b01383 Soo Choi, 2007, Renal clearance of quantum dots, Nat Biotechnol, 25, 1165, 10.1038/nbt1340 Du, 2018, Transport and interactions of nanoparticles in the kidneys, Nat Rev Mater, 3, 358, 10.1038/s41578-018-0038-3 Charles, 2001, The complement system and innate immunity Barbero, 2017, Formation of the protein corona: the interface between nanoparticles and the immune system, Seminars Immunol, 34, 52, 10.1016/j.smim.2017.10.001 Wang, 2016, Activation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran/Fe ratio, hydroxyl modifications, and crosslinking, Front Immunol, 7, 10.3389/fimmu.2016.00418 Chen, 2017, Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo, Nat Nanotechnol, 12, 387, 10.1038/nnano.2016.269 Buchman, 2019, Understanding nanoparticle toxicity mechanisms to inform redesign strategies to reduce environmental impact, Acc Chem Res, 52, 1632, 10.1021/acs.accounts.9b00053 Huang, 2017, The toxicity of nanoparticles depends on multiple molecular and physicochemical mechanisms, Int J Mol Sci, 18, 10.3390/ijms18122702 Kirchner, 2005, Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles, Nano Lett, 5, 331, 10.1021/nl047996m Xia, 2008, Comparison of the mechanism of toxicity of Zinc Oxide and Cerium Oxide nanoparticles based on dissolution and oxidative stress properties, ACS Nano, 2, 2121, 10.1021/nn800511k Jayaram, 2017, Nanoparticle-induced oxidation of corona proteins initiates an oxidative stress response in cells, Nanoscale, 9, 7595, 10.1039/C6NR09500C Leroueil, 2008, Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers, Nano Lett, 8, 420, 10.1021/nl0722929 Wang, 2013, The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes, Nanomedicine, 9, 1159, 10.1016/j.nano.2013.04.010 Linse, 2007, Nucleation of protein fibrillation by nanoparticles, Proc Natl Acad Sci USA, 104, 8691, 10.1073/pnas.0701250104 Fernández, 2016, Nucleation of amyloid oligomers by RepA-WH1-prionoid-functionalized gold nanorods, Angew Chem Int Ed, 55, 11237, 10.1002/anie.201604970 Yang, 2014, α-Synuclein’s adsorption, conformation, and orientation on cationic gold nanoparticle surfaces seeds global conformation change, J Phys Chem B, 118, 3559, 10.1021/jp501114h Schwenk, 2017, The human plasma proteome draft of 2017: building on the human plasma peptide. Atlas from mass spectrometry and complementary assays, J Proteome Res, 16, 4299, 10.1021/acs.jproteome.7b00467 Anderson, 2002, The human plasma proteome: history, character, and diagnostic prospects, Mol Cell Proteom, 1, 845, 10.1074/mcp.R200007-MCP200 2008, 17 Gianazza, 2016, With or without you - proteomics with or without major plasma/serum proteins, J Proteomics, 140, 62, 10.1016/j.jprot.2016.04.002 2008, 393 Fanali, 2012, Human serum albumin: from bench to bedside, Mol Aspects Med, 33, 209, 10.1016/j.mam.2011.12.002 Busher, 1990, Serum albumin and globulin 2008, 195 Sobczynski, 2017, IgA and IgM protein primarily drive plasma corona‐induced adhesion reduction of PLGA nanoparticles in human blood flow, Bioeng Transl Med, 2, 180, 10.1002/btm2.10064 2008, 89 Wang, 2019, Exploring the conformational changes in fibrinogen by forming protein corona with CdTe quantum dots and the related cytotoxicity, Spectrochim Acta A, 220, 10.1016/j.saa.2019.117143 2008, 151 Moghimi, 2011, Material properties in complement activation, Adv Drug Deliv Rev, 63, 1000, 10.1016/j.addr.2011.06.002 Feingold, 2018 Kreuter, 2002, Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier, J Drug Target, 10, 317, 10.1080/10611860290031877 Wagner, 2012, Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model, PLoS One, 7, 10.1371/journal.pone.0032568 Jain, 2011, Acute-phase proteins: as diagnostic tool, J Pharm Bioallied Sci, 3, 118, 10.4103/0975-7406.76489 Vilanova, 2016, Understanding the kinetics of protein–nanoparticle corona formation, ACS Nano, 10, 10842, 10.1021/acsnano.6b04858 Nel, 2009, Understanding biophysicochemical interactions at the nano–bio interface, Nat Mater, 8, 543, 10.1038/nmat2442 Prozeller, 2019, Isothermal titration calorimetry as a complementary method for investigating nanoparticle–protein interactions, Nanoscale, 11, 19265, 10.1039/C9NR05790K Segets, 2011, Experimental and theoretical studies of the colloidal stability of nanoparticles−A general interpretation based on stability maps, ACS Nano, 5, 4658, 10.1021/nn200465b CAS, 2015, Nonadditivity of nanoparticle interactions, Science, 350 Dominguez-Medina, 2013, Adsorption of a protein monolayer via hydrophobic interactions prevents nanoparticle aggregation under harsh environmental conditions, ACS Sustainable Chem Eng, 1, 833, 10.1021/sc400042h Shakhnovich, 2006, Protein folding thermodynamics and dynamics: where physics, chemistry and biology meet, Chem Rev, 106, 1559, 10.1021/cr040425u Onuchic, 1997, Theory of protein folding: the energy landscape perspective, Annu Rev Phys Chem, 48, 545, 10.1146/annurev.physchem.48.1.545 1985 Solá, 2006, Engineering of protein thermodynamic, kinetic, and colloidal stability: chemical glycosylation with monofunctionally activated glycans, Biotechnol Bioeng, 94, 1072, 10.1002/bit.20933 Southall, 2002, A View of the hydrophobic effect, J Phys Chem B, 106, 521, 10.1021/jp015514e Wang, 2019, Formation of a monolayerprotein corona around polystyrene nanoparticles and implications for nanoparticle agglomeration, Small, 15 Liu, 2019, Adsorption of human serum albumin on graphene oxide: implications for protein corona formation and conformation, Environ Sci Technol, 53, 8631, 10.1021/acs.est.8b03451 Nasir, 2015, Size and surface chemistry of nanoparticles lead to a variant behavior in the unfolding dynamics of human carbonic anhydrase, Nanoscale, 7, 17504, 10.1039/C5NR05360A Browne, 2004, Protein adsorption onto polystyrene surfaces studied by XPS and AFM, Surface Sci, 553, 155, 10.1016/j.susc.2004.01.046 Vallee, 2010, Peptide interactions with metal and oxide surfaces, Acc Chem Res, 43, 1297, 10.1021/ar100017n Siriwardana, 2013, Probing the effects ofcysteine residues on protein adsorption onto gold nanoparticles using wild-type and mutated GB3 proteins, Langmuir, 29, 10990, 10.1021/la402239h Costa, 2016, Adsorption of amino acids and peptides on metal and oxide surfaces in water environment: a synthetic and prospective review, J Phys Chem B, 120, 7039, 10.1021/acs.jpcb.6b05954 Lai, 2017, Interaction of gold and silver nanoparticles with human plasma: analysis of protein corona reveals specific binding patterns, Colloids Surf B, 152, 317, 10.1016/j.colsurfb.2017.01.037 Goy-López, 2012, Physicochemical characteristics of protein–NP bioconjugates: The role of particle curvature and solution conditions on human serum albumin conformation and fibrillogenesis inhibition, Langmuir, 28, 9113, 10.1021/la300402w Shemetov, 2012, Molecular interaction of proteins and peptides with nanoparticles, ACS Nano, 6, 4585, 10.1021/nn300415x Chiu, 2009, Size-dependent hydrophobic to hydrophilic transition for nanoparticles: a molecular dynamics study, J Chem Phys, 131, 10.1063/1.3276915 Wang, 2011, How and why nanoparticle’s curvature regulates the apparent pKa of the coating ligands, J Am Chem Soc, 133, 2192, 10.1021/ja108154a SHDP, 2010, Interaction of gold nanoparticles with common human blood proteins, ACS Nano, 4, 365, 10.1021/nn9011187 Lindman, 2007, Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/ N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity, Nano Lett, 7, 7, 10.1021/nl062743+ Shang, 2007, Unfolding of ribonuclease A on silica nanoparticle surfaces, Nano Lett, 7, 1991, 10.1021/nl070777r Gabellieri, 2011, Protein structural changes induced by glutathione-coated CdS quantum dots as revealed by Trp phosphorescence, Eur Biophys J, 40, 1237, 10.1007/s00249-011-0736-x Roach, 2006, Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry, J Am Chem Soc, 128, 3939, 10.1021/ja056278e Asuri, 2006, Increasing protein stability through control of the nanoscale environment, Langmuir, 22, 5833, 10.1021/la0528450 García-Álvarez, 2018, In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape, Nanoscale, 10, 1256, 10.1039/C7NR08322J Visalakshan, 2020, The influence of nanoparticle shape on protein corona formation, Small, 16 Lundqvist, 2008, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc Natl Acad Sci U S A, 105, 14265, 10.1073/pnas.0805135105 Quach, 2018, Complement activation by gold nanoparticles passivated with polyelectrolyte ligands, RSC Adv, 8, 6616, 10.1039/C7RA13325A Prozeller, 2020, Immunoglobulins on the surface of differently charged polymer nanoparticles, Biointerphases, 15, 10.1116/6.0000139 Dennison, 2017, Protein adsorption to charged gold nanospheres as a function of protein deformability, Langmuir, 33, 7751, 10.1021/acs.langmuir.7b01909 Perng, 2019, Elucidating the role of surface coating in the promotion or prevention of protein corona around Quantum Dots, Bioconjugate Chem, 30, 2469, 10.1021/acs.bioconjchem.9b00549 Deng, 2012, Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses, Nanotoxicology, 7, 314, 10.3109/17435390.2012.655342 Vidaurre-Agut, 2019, Protein corona over mesoporous silica nanoparticles: influence of the pore diameter on competitive adsorption and application to prostate cancer diagnostics, ACS Omega, 4, 8852, 10.1021/acsomega.9b00460 Casals, 2010, Time evolution of the nanoparticle protein corona, ACS Nano, 4, 3623, 10.1021/nn901372t Lynch, 2008, Protein-nanoparticle interactions, Nano Today, 3, 40, 10.1016/S1748-0132(08)70014-8 Barrán-Berdón, 2013, Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery, Langmuir, 29, 6485, 10.1021/la401192x Vroman, 1969, Findings with the recording ellipsometer suggesting rapid exchange of specific plasma proteins at liquid/solid interfaces, Surface Sci., 16, 438, 10.1016/0039-6028(69)90037-5 Jung, 2003, The Vroman effect: a molecular level description of fibrinogen displacement, J Am Chem Soc, 125, 12782, 10.1021/ja037263o Wojciechowski, 1986, Phenomenology and mechanism of the transient adsorption of fibrinogen from plasma (Vroman effect), J Colloid Interface Sci, 111, 455, 10.1016/0021-9797(86)90048-2 Tenzer, 2013, Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology, Nat Nanotechnol, 8, 772, 10.1038/nnano.2013.181 Liu, 2013, Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?, Nanoscale, 5, 1658, 10.1039/c2nr33611a Monopoli, 2011, Physical−chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles, J Am Chem Soc, 133, 2525, 10.1021/ja107583h Lundqvist, 2011, The evolution of the protein corona around nanoparticles: a test study, ACS Nano, 5, 7503, 10.1021/nn202458g Kokkinopoulou, 2017, Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions, Nanoscale, 9, 8858, 10.1039/C7NR02977B Milani, 2012, Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona, ACS Nano, 6, 2532, 10.1021/nn204951s Winzen, 2015, Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition, Nanoscale, 7, 2992, 10.1039/C4NR05982D Zhang, 2020, An analysis of the binding function and structural organization of the protein corona, J Am Chem Soc, 142, 8827, 10.1021/jacs.0c01853 Chen, 2008, Nanosilver: a nanoproduct in medical application, Toxicol Lett, 176, 1, 10.1016/j.toxlet.2007.10.004 Mason, 2016, 134 Morsbach, 2018, Engineering proteins at interfaces: from complementary characterization to material surfaces with designed functions, Angew Chem Int Ed Engl, 57, 12626, 10.1002/anie.201712448 Pinals, 2020, Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function, Analyst, 145, 5090, 10.1039/D0AN00633E Chen, 2005, Polyethylene glycol and solutions of polyethylene glycol as green reaction media, Green Chem, 7, 64, 10.1039/b413546f D’souza, 2016, Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications, Expert Opin Drug Delivery, 13, 1257, 10.1080/17425247.2016.1182485 Karaman, 2011, Polyethylene glycol (PEG)/diatomite composite as a novel form-stable phase change material for thermal energy storage, Sol Energy Mater Sol Cells, 95, 1647, 10.1016/j.solmat.2011.01.022 Zhang, 2012, Ultrahigh nanoparticle stability against salt, pH, and solvent with retained surface accessibility via depletion stabilization, J Am Chem Soc, 134, 9910, 10.1021/ja303787e Mei, 2009, Effects of ligand coordination number and surface curvature on the stability of gold nanoparticles in aqueous solutions, Langmuir, 25, 10604, 10.1021/la901423z Schöttler, 2016, Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers, Nat Nanotechnol, 11, 372, 10.1038/nnano.2015.330 Abuchowski, 1977, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase, J Biol Chem, 252, 3582, 10.1016/S0021-9258(17)40292-4 Lowe, 2014, Antibiofouling polymer interfaces: poly(ethylene glycol) and other promising candidates, Polym Chem, 6, 198, 10.1039/C4PY01356E Alberg, 2020, Polymeric nanoparticles: polymeric nanoparticles with neglectable protein corona, Small, 16 Dormidontova, 2002, Role of competitive PEO−water and water−water hydrogen bonding in aqueous solution PEO behavior, Macromolecules, 35, 987, 10.1021/ma010804e Lüsse, 1996, The interaction of poly(ethylene glycol) with water studied by 1H and 2H NMR relaxation time measurements, Macromolecules, 29, 4251, 10.1021/ma9508616 Seneca, 2018, How low can you go? low densities of poly(ethylene glycol) surfactants attract stealth proteins, Macromol Biosci, 18, 10.1002/mabi.201800075 Currie, 2003, Tethered polymer chains: surface chemistry and their impact on colloidal and surface properties, Adv Colloid Interface Sci, 100–102, 205, 10.1016/S0001-8686(02)00061-1 Jeon, 1991, Protein—surface interactions in the presence of polyethylene oxide: I. Simplified theory, J Colloid Interface Sci, 142, 149, 10.1016/0021-9797(91)90043-8 Schlenoff, 2014, Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption, Langmuir, 30, 9625, 10.1021/la500057j Perry, 2012, PEGylated print nanoparticles: The impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics, Nano Lett, 12, 5304, 10.1021/nl302638g Yang, 2014, Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation, Mol Pharmaceutics, 11, 1250, 10.1021/mp400703d Lee, 2016, Adsorption of plasma proteins onto PEGylated lipid bilayers: the effect of PEG size and grafting density, Biomacromolecules, 17, 1757, 10.1021/acs.biomac.6b00146 Li, 2019, Cross-linked poly(ethylene glycol) shells for nanoparticles: enhanced stealth effect and colloidal stability, Langmuir, 35, 8799, 10.1021/acs.langmuir.9b01325 Li, 2015, Mussel-inspired antifouling coatings bearing polymer loops, Chem Commun, 51, 15780, 10.1039/C5CC06852E Kozma, 2020, Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals, Adv Drug Deliv Rev, 10.1016/j.addr.2020.07.024 Guan, 2018, Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption, Nat Commun, 9, 2982, 10.1038/s41467-018-05384-1 Simon, 2018, Protein corona mediated stealth properties of biocompatible carbohydrate-based nanocarriers, Isr J Chem, 58, 1363, 10.1002/ijch.201800166 Zou, 2020, Polyglycerol grafting shields nanoparticles from Protein corona formation to avoid macrophage uptake, ACS Nano, 14, 7216, 10.1021/acsnano.0c02289 Knop, 2010, Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives, Angew Chem Int Ed, 49, 6288, 10.1002/anie.200902672 Yang, 2015, Anti-PEG immunity: emergence, characteristics, and unaddressed questions, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 7, 655, 10.1002/wnan.1339 Verhoef, 2013, Questioning the use of PEGylation for drug delivery, Drug Deliv Transl Res, 3, 499, 10.1007/s13346-013-0176-5 van Meer, 2008, Membrane lipids: where they are and how they behave, Nat Rev Mol Cell Biol, 9, 112, 10.1038/nrm2330 Andrade, 1986, 1 Laughlin, 1991, Fundamentals of the zwitterionic hydrophilic group, Langmuir, 7, 842, 10.1021/la00053a006 Kitano, 2002, Hydrogen-bonded network structure of water in aqueous solution of sulfobetaine polymers, J Phys Chem B, 106, 11391, 10.1021/jp020185r Schlenoff, 2008, Hydration contributions to association in polyelectrolyte multilayers and complexes: visualizing hydrophobicity, J Am Chem Soc, 130, 13589, 10.1021/ja802054k Mahon, 2008, Interactions of poly(2-methacryloyloxyethyl phosphorylcholine) with various salts studied by size exclusion chromatography, Colloid Polym Sci, 286, 1443, 10.1007/s00396-008-1915-x Affonso de Oliveira, 2018, Dual functionalization of nanoparticles for generating corona-free and noncytotoxic silica nanoparticles, ACS Appl Mater Interfaces, 10, 41917, 10.1021/acsami.8b12351 Oh, 2018, Cloaking nanoparticles with protein corona shield for targeted drug delivery, Nat Commun, 9, 4548, 10.1038/s41467-018-06979-4